Share this postCopy linkFacebookEmailNotesMoreMendelspod PodcastLong DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech 8Share this postCopy linkFacebookEmailNotesMore11×Preview0:00Current time: 0:00 / Total time: -8:12-8:12Audio playback is not supported on your browser. Please upgrade.Long DNA for Difficult Applications: Dan Lin-Arlow, CEO, Ansa Biotech Theral TimpsonSep 13, 2023∙ Paid8Share this postCopy linkFacebookEmailNotesMore1ShareChapters:0:00 World’s longest oligo8:45 Why is it difficult to synthesize long DNA?12:00 Proprietary TdT conjugate16:00 A billion-dollar market24:20 The computation model and its challenges28:35 More customers using generative AIMendelspod is now reader supported. Please consider upgrading to a paid subscription for the price of a couple cof…SubscribeThis post is for paid subscribersSubscribeAlready a paid subscriber? Sign inMendelspod PodcastOffering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.Offering a front row seat to the Century of Biology, veteran podcast host Theral Timpson interviews the who's who in genomics and genomic medicine.SubscribeListen onSubstack AppRSS FeedAppears in episodeTheral TimpsonRecent EpisodesAI Powered Multiomics: Joachim Schmid on Data Analysis at IlluminaNov 21 • Theral TimpsonRenowned GI Oncologist Discusses MRD Testing and the Future of Cancer DetectionNov 14 • Theral TimpsonPrecision Medicine Then and Now: We Talk with the Retiring President of the Personalized Medicine Coalition, Ed AbrahamsNov 12 • Theral TimpsonMicroRNA: A New Era in Biomarker Discovery with Tim Williams and Paola UliviNov 7 • Theral TimpsonSomatic Genomics: A Revolution in Biology with Jacob RubensOct 31 • Theral TimpsonExploring the Future of Single Cell Technology with Mauro Muraro, CEO, Single Cell Discoveries Oct 29 • Theral TimpsonGrail and Verily Alum on Billion Dollar Startup Bringing AI to Drug Development: A Discussion with Vik BajajOct 17 • Theral TimpsonSingular Genomics Introduces a Dual-Purpose Platform Capable of Both NGS and Spatial Multiomics: Drew Spaventa, CEO & Founder Oct 15 • Theral Timpson